Bausch Health Competitors and Similar CompaniesClear all
Bausch Health's competitors and similar companies include Pfizer, Merck, Novartis, GSK and Sanofi.
 Bausch Health Bausch Health is a company that develops, manufactures, and markets a range of pharmaceutical, medical device, and over-the-counter (OTC) products. |  Pfizer Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products. |  Merck Merck (also known as MSD) is a company that develops and manufactures medicines and vaccines for human and animal health. |  Novartis Novartis is a company that researches, develops, manufactures, and markets healthcare products. |  GSK GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products. |  Sanofi Sanofi is a healthcare company engaged in the research, development, manufacture, and marketing of therapeutic solutions. | |
Founding Date | Founding Date 1959 | Founding Date 1849 | Founding Date 1891 | Founding Date 1996 | Founding Date 2000 | Founding Date 1994 |
Type | Type Public | Type Public | Type Public | Type Public | Type Public | Type Public |
Tags | ||||||
Locations | Locations Laval, CA HQ Buenos Aires, AR Wien, AT Sarajevo, BA Indaiatuba, BR Porto Alegre, BR Sao Paulo, BR see more | Locations New York, US HQ Buenos Aires, AR Villa Adelina, AR Footscray, AU Mulgrave, AU Sydney, AU Wien, AT see more | Locations Rahway, US HQ Munro, AR Macquarie Park, AU Krems An Der Donau, AT Wien, AT Bruxelles, BE Santa Cruz De La Sierra, BO see more | Locations Basel, CH HQ Tirana, AL Buenos Aires, AR Macquarie Park, AU Kundl, AT Unterlangkampfen, AT Wien, AT see more | Locations London, GB HQ Boumerdes, DZ Buenos Aires, AR Abbotsford, AU Wien, AT Wavre, BE Rio De Janeiro, BR see more | Locations Paris, FR HQ Hydra, DZ Buenos Aires, AR Macquarie Park, AU Melbourne, AU Virginia, AU Wien, AT see more |
Employees | Employees 20,700 | Employees 81,0008% decrease | Employees 73,0004% increase | Employees 75,883 | Employees 68,629 | Employees 82,878 |
Valuation ($) | Valuation ($) 3 b | Valuation ($) 163.9 b | Valuation ($) 294.7 b | Valuation ($) N/A | Valuation ($) 862.5 m | Valuation ($) 141.1 b |
Financial | ||||||
Revenue (est.) | Revenue (est.) $10.3b (FY, 2025) | Revenue (est.) $62.6b (FY, 2025) | Revenue (est.) $65b (FY, 2025) | Revenue (est.) $56.7b (FY, 2025) | Revenue (est.) £32.7b (FY, 2025) | Revenue (est.) €45.4b (FY, 2025) |
Cost of goods | Cost of goods $1.7b (FY, 2025) | Cost of goods $16.1b (FY, 2025) | Cost of goods $16.4b (FY, 2025) | Cost of goods $8.4b (FY, 2025) | Cost of goods £5.6b (FY, 2025) | Cost of goods €11.6b (FY, 2025) |
Gross profit | Gross profit $8.5b (FY, 2025) | Gross profit $46.5b (FY, 2025) | Gross profit $48.6b (FY, 2025) | Gross profit $49.8b (FY, 2025) | Gross profit £28.5b (FY, 2025) | Gross profit €37.6b (FY, 2025) |
Net income | Net income $120m (FY, 2025) | Net income $7.8b (FY, 2025) | Net income $18.3b (FY, 2025) | Net income $14b (FY, 2025) | Net income £6.3b (FY, 2025) | Net income €8b (FY, 2025) |
Operating ⚠ | ||||||
Countries | Countries N/A | Countries 200 (FY, 2024) | Countries N/A | Countries N/A | Countries 92 (FY, 2021) | Countries N/A |
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products 51 (FY, 2024) | Phase I Trials Products N/A | Phase I Trials Products N/A | Phase I Trials Products 16 (FY, 2021) | Phase I Trials Products N/A |
Phase II Trials Products | Phase II Trials Products N/A | Phase II Trials Products 27 (FY, 2024) | Phase II Trials Products 85 (FY, 2022) | Phase II Trials Products N/A | Phase II Trials Products 6 (FY, 2021) | Phase II Trials Products N/A |
Phase III Trials Products | Phase III Trials Products N/A | Phase III Trials Products 32 (FY, 2024) | Phase III Trials Products 32 (FY, 2022) | Phase III Trials Products 44 (FY, 2022) | Phase III Trials Products 11 (FY, 2021) | Phase III Trials Products N/A |
Projects in R&D Pipeline | Projects in R&D Pipeline 225 (FY, 2019) | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline N/A | Projects in R&D Pipeline 91 (FY, 2019) |
Registration Phase Products | Registration Phase Products N/A | Registration Phase Products 5 (FY, 2024) | Registration Phase Products N/A | Registration Phase Products 8 (FY, 2022) | Registration Phase Products N/A | Registration Phase Products N/A |
Suppliers | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers N/A | Suppliers 37.5 k (FY, 2021) | Suppliers 68 k (FY, 2019) |
Funding | ||||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 6.5m | Total funding raised N/A | Total funding raised $ 310m |
For sources of this data, please see the company profile
View Company Profiles
Pfizer
HQ
New York, US
Employees
81,000↓ 8% decrease
Pfizer is a research-based biopharmaceutical company engaged in the discovery, development, manufacture, and distribution of healthcare products.
View companyMerck
HQ
Rahway, US
Employees
73,000↑ 4% increase
Merck (also known as MSD) is a company that develops and manufactures medicines and vaccines for human and animal health.
View companyNovartis
HQ
Basel, CH
Employees
75,883
Novartis is a company that researches, develops, manufactures, and markets healthcare products.
View companyGSK
HQ
London, GB
Employees
68,629
GSK (GlaxoSmithKline) is a science-led healthcare company that researches, develops, and manufactures pharmaceutical medicines, vaccines, and consumer healthcare products.
View company